Interleukin-2: inception, impact, and implications - PubMed (original) (raw)

Review

. 1988 May 27;240(4856):1169-76.

doi: 10.1126/science.3131876.

Affiliations

• PMID: 3131876
• DOI: 10.1126/science.3131876

Review

Interleukin-2: inception, impact, and implications

K A Smith. Science. 1988.

Abstract

Interleukin-2 (IL-2), the first of a series of lymphocytotrophic hormones to be recognized and completely characterized, is pivotal for the generation and regulation of the immune response. A T lymphocyte product, IL-2 also stimulates T cells to undergo cell cycle progression via a finite number of interactions with its specific membrane receptors. Because T cell clonal proliferation after antigen challenge is obligatory for immune responsiveness and immune memory, the IL-2-T cell system has opened the way to a molecular understanding of phenomena that are fundamental to biology, immunology, and medicine.

PubMed Disclaimer

Similar articles

• Interleukin 2.
  Smith KA. Smith KA. Annu Rev Immunol. 1984;2:319-33. doi: 10.1146/annurev.iy.02.040184.001535. Annu Rev Immunol. 1984. PMID: 6443342 Review. No abstract available.
• Interleukin-2 (IL-2) and its receptor.
  Larsson EL. Larsson EL. Med Oncol Tumor Pharmacother. 1986;3(3-4):231-6. doi: 10.1007/BF02934999. Med Oncol Tumor Pharmacother. 1986. PMID: 3100883 Review.
• The interleukin 2 receptor and its physiology. Implications for combatting autoimmune diseases and transplant rejections.
  Diamantstein T. Diamantstein T. Behring Inst Mitt. 1987 Jun;(81):73-87. Behring Inst Mitt. 1987. PMID: 3115248 No abstract available.
• A study of cyclic nucleotides as second messengers after interleukin 2 stimulation of human T lymphocytes.
  Knudsen TE, Larsen CS, Johnsen HE. Knudsen TE, et al. Scand J Immunol. 1987 May;25(5):527-31. doi: 10.1111/j.1365-3083.1987.tb02224.x. Scand J Immunol. 1987. PMID: 3035707

Cited by

• Biomimetic cell stimulation with a graphene oxide antigen-presenting platform for developing T cell-based therapies.
  Zhu E, Yu J, Li YR, Ma F, Wang YC, Liu Y, Li M, Kim YJ, Zhu Y, Hahn Z, Zhou Y, Brown J, Zhang Y, Pelegrini M, Hsiai T, Yang L, Huang Y. Zhu E, et al. Nat Nanotechnol. 2024 Dec;19(12):1914-1922. doi: 10.1038/s41565-024-01781-4. Epub 2024 Sep 23. Nat Nanotechnol. 2024. PMID: 39313679
• Therapeutic efficacy of monthly subcutaneous injection of daclizumab in relapsing multiple sclerosis.
  Cohan S. Cohan S. Biologics. 2016 Sep 12;10:119-38. doi: 10.2147/BTT.S89218. eCollection 2016. Biologics. 2016. PMID: 27672308 Free PMC article. Review.
• CD275-Independent IL-17-Producing T Follicular Helper-like Cells in Lymphopenic Autoimmune-Prone Mice.
  Smith C, Buhlmann JE, Wang X, Bartlett A, Lim B, Barrington RA. Smith C, et al. J Immunol. 2016 Jun 15;196(12):4935-46. doi: 10.4049/jimmunol.1402193. Epub 2016 May 16. J Immunol. 2016. PMID: 27183569 Free PMC article.
• Identification of multiple cis-elements and trans-acting factors involved in the induced expression of human IL-2 gene.
  Shibuya H, Taniguchi T. Shibuya H, et al. Nucleic Acids Res. 1989 Nov 25;17(22):9173-84. doi: 10.1093/nar/17.22.9173. Nucleic Acids Res. 1989. PMID: 2555786 Free PMC article.
• Stimulation of human peripheral blood mononuclear cells by the sialic acid precursor N-propanoylmannosamine.
  Roehlecke C, Horstkorte R, Reutter W. Roehlecke C, et al. Glycoconj J. 2013 Nov;30(8):813-8. doi: 10.1007/s10719-013-9485-7. Epub 2013 Jun 30. Glycoconj J. 2013. PMID: 23813293

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon

• Other Literature Sources

  • The Lens - Patent Citations Database